¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Enduring personality change after catastrophic experience"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 2
¿µ¹® narcissistic personality disorder ÇÑ±Û ÀÚ±â¾ÖÀû ÀΰÝÀå¾Ö
¼³¸í   
  ÀÚ½ÅÀÇ Á߿伺°ú µ¶Æ¯ÇÔ, À¯ÀÏÇÔ¿¡ ´ëÇÑ ±¤ÀûÀΠÁýÂø°ú ÀÚ½ÅÀÌ ¼º°øÇÒ °ÍÀ̶ó´Â Áö³ªÄ£ ÁýÂøÀ» º¸¿©Áִ ¼º°ÝÀå¾Ö. Áö³ªÄ£ Àڱ⿡ÀÇ ¸¸Á·°¨À» °¡Áö°í, Áö³ªÄ£ Àڽۨ, ¼º°ø¿¡ ´ëÇÑ È®½ÅÀ» Áö´Ï°í ÀÖ´Ù.
¿µ¹® histrionic personality disorder ÇÑ±Û È÷½ºÅ׸®ÀΰÝÀå¾Ö
¼³¸í   
  Áö³ªÄ¡°Ô ¿¬±ØÀûÀÌ°í ¹ÝÀÀÀûÀ̸ç ÇൿÀÇ Áö³ªÄ£ Ç¥Çö ¹× Æ¯À¯ÇÑ ´ëÀΰü°èÀÇ Àå¾Ö¸¦ ÁַΠÇϴ Á¤½Åº´. È÷½ºÅ׸®ÀΰÝÀå¾Ö´Â ¿ÜºÎ¿¡ ´ëÇÑ ¹ÝÀÀÀÌ Áö³ªÄ¡°Ô ºü¸£°í Àڱ⸦ °ú½ÃÇ졒ʫëÀΰü°è¿¡¼­ ÇÇ»óÀûÀÌ°í ºÒ¼º½ÇÇØ¼­ ´ëÀΰü°è¿¡ Àå¾Ö°¡ Àִ À̻󼺰ÝÀ¸·Î¼­ ¼º½É¸®°¡ ¹Ì¼÷ÇÑ °ÍÀ̠Ư¡ÀÌ´Ù. ¾ðÁ¦³ª ÀÚ½ÅÀ» ¸ÚÁö°Ô µå·¯³» º¸ÀÌ·Á ÇÏ°í ´Ù¸¥ »ç¶÷ÀÇ °ü½ÉÀ» ²ø±â À§ÇØ °úÀåµÈ Ç¥ÇöÀ» ÇÑ´Ù. ¾Æ´Â »ç¶÷À» ¸¸³ª¸é Áö³ªÄ¥ Á¤µµ·Î ¹Ý°¡¿öÇÏ°í ¸¶Ä¡ °øÁÖ³ª ¿ÕÀÚ°°Àº Ç༼¸¦ Çϴ ¼ö°¡ ÀÖ´Ù. ÀÛÀº Àڱؿ¡µµ ½±°Ô ÈïºÐÇϰí È­¸¦ Àß ³»³ª ÀÛÀº ±â»Ý¿¡ Áö³ªÄ¡°Ô ¹ÝÀÀÇϴ º¯´ö½º·¯¿î ¼º°ÝÀÇ ¼ÒÀ¯ÀÚÀÌ´Ù. ³í¸®ÀûÀΠ°Íº¸´Ù´Â °¨Á¤ÀûÀ¸·Î ÀÏÀ» Ã³¸®Ç졒ʫëÀΰü°è¿¡¼­ »ó´ë¹æÀÇ Àǻ縦 ÀÚ±â È¯»ó¿¡ µû¶ó ¸Ú´ë·Î Çؼ®ÇÑ´Ù. ºÒ¸¸½º·¯¿î ÀÏÀÌ ÀÖÀ¸¸é ÀÚ»ìÇÑ´Ù°í À§ÇùÇϰųª ÀÚ»ìÀÇ ¿¬±ØÀ» ²Ù¸ç¼­ »ó´ë¹æÀ» Á¶Á¤ÇÑ´Ù. Ç¥¸éÀûÀ¸·Î´Â °¨Á¤À̠dzºÎÇÏ°í ¸Å·ÂÀûÀÌ°í »ç±Í±â ½±Áö¸¸ ´ëÀΰü°è¿¡¼­ Áö¼Ó¼ºÀÌ ¾ø°í ½±°Ô »ç±Í¾ú´Ù°¡ ½±°Ô Çì¾îÁö°í ±³Á¦Çϴ »ç¶÷Àº ¸¹À¸³ª »ó´ë°¡ ÀÚÁÖ ¹Ù²ï´Ù. Çѹø »ç±Í°Ô µÇ¸é »ó´ë¹æÀÇ ÀÇ»ç´Â ¾Æ¶û°÷ÇÏÁö ¾Ê°í Àڱ⠿䱸¸¸ µé¾îÁֱ⸦ ¹Ù¶ó´Â À̱âÀûÀΠ»ç¶÷ÀÌ°í ±×°ÍÀÌ ÃæÁ·µÇÁö ¸øÇϸ頰ð ½Ç¸ÁÇÏ°í ±× »ç¶÷À» ¿ø¸ÁÇÑ´Ù. ¼ºÀû ÀûÀÀ·Âµµ Èñ¹ÚÇÏ¿© ¼ºÀûÀ¸·Î ¸Å·ÂÀÌ À־¸ÀÌ°í ¾Ö±³°¡ ÀÖ°í ¼ºÀû ºÐÀ§±â¸¦ ¹°¾À Ç³±âÁö¸¸ ºÒ°¨ÁõÀΠ°æ¿ì°¡ ¸¹´Ù. À̼º°ü°è¸¦ ³¶¸¸ÀûÀΠȯ»óÀ¸·Î ²ø°í °¡·Á°í ÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • apathetic personality
    ¹«°¨µ¿ÀΰÝ
  • as-if personality
    °¡ÀåÀΰÝ
  • asocial personality disorder
    ºñ»çȸÀûÀΰÝÀå¾Ö
  • authoritarian personality
    ±ÇÀ§Àû¼º°Ý
  • avoidant personality disorder
    ȸÇÇÀΰÝÀå¾Ö
  • aggressive personality
    °ø°ÝÀûÀΰÝ
  • alternating personality
    ±³´ëÀΰÝ
  • amoral personality
    ºñµµ´öÀΰÝ
  • anal personality
    Ç×¹®±âÀΰÝ
  • anankastic personality
    °­¹ÚÀΰÝ
  • anankastic personality disorder
    °­¹ÚÀΰÝÀå¾Ö
  • borderline personality disorder
    °æ°èÀΰÝÀå¾Ö
  • compulsive personality disorder
    °­¹ÚÀΰÝÀå¾Ö
  • cycloid personality
    ¼øÈ¯ÇüÀΰÝ
  • cyclothymic personality
    ¼øÈ¯±âºÐÀΰÝ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • anal personality
    Ç×¹®±âÀΰÝ
  • anankastic personality
    (¢¡obsessive-compulsive personality) °­¹ÚÀΰÝ
  • anankastic personality disorder
    °­¹ÚÀΰÝÀå¾Ö
  • antisocial personality
    ¹Ý»çȸÀΰÝ
  • antisocial personality disorder
    ¹Ý»çȸÀΰÝÀå¾Ö
  • anxious and fearful personality
    ºÒ¾È°øÆ÷ÀΰÝ
  • anxious personality disorder
    ºÒ¾ÈÀΰÝÀå¾Ö
  • apathetic personality
    ¹«°¨µ¿ÀΰÝ
  • as-if personality
    °¡ÀåÀΰÝ
  • asocial personality disorder
    ºñ»çȸÀΰÝÀå¾Ö
  • avoidant personality disorder
    ȸÇÇÀΰÝÀå¾Ö
  • borderline personality disorder
    °æ°èÀΰÝÀå¾Ö, ÁØÀΰÝÀå¾Ö
  • compulsive personality disorder
    °­¹ÚÀΰÝÀå¾Ö
  • cycloid personality
    ¼øÈ¯ÇüÀΰÝ
  • cyclothymic personality
    ¼øÈ¯±âºÐ¼ºÀΰÝ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • after-load
    ÈĺÎÇÏ(ý­Ý¶ùÃ)
  • after-movement
    ÈĿ(Ì·ËôËÄ).
  • after-nystagmus
    ÈĹ߾ÈÁø
  • after-pain
    ÈÄÁøÅë(ý­òæ÷Ô).
  • after-vision
    ÀÜ»ó½Ã°¢(íÑßÀò±ÊÆ).
  • positive after image
    ¾ç¼ºÀÜ»ó(åÕàõíÑßÀ).
  • positive after potential
    ¾ç¼ºÈÄÀüÀ§(åÕàõý­ï³êÈ).
  • Minnesota Multiphasic Personality Inventory(MMPI)
    ¹Ì³×¼ÒŸ´Ù¸éÀûÀμº°Ë»ç(~ÒýØüîÜìÑàõËþÞÛ)
  • acromegalic personality
    ¼±´Ü°Å´ë¼º ÀÎ°Ý (¡­ìÑÌ«).
  • alternating personality
    ±³´ë¼º ÀÎ°Ý (¡­ìÑÌ«).
  • anal personality
    Ç×¹®±âÀΰÝ.
  • antisocial personality
    ¹Ý»çȸÀû ÀΰÝ.
  • antisocial personality disorder
    ¹Ý»çȸ¼º ÀΰÝÀå¾Ö
  • asocial personality
    ºñ»çȸ¼º ÀΰÝ
  • hysterical personality =h. character
    È÷½ºÅ׸®¼º ÀΰÝ,È÷½ºÅ׸®¼º°Ý
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • after-depolarization
    ÈÄÅ»ºÐ±Ø(ý­÷­ÝÂп)
  • after-discharge
    ÈĹ߻ç(ý­Û¡ÞÒ) ¹Ý»çÀÇ
  • after-load
    ÈĺÎÇÏ(ý­Ý¶ùÃ)
  • after-movement
    ÈĿ(Ì·ËôËÄ).
  • after-nystagmus
    ÈĹ߾ÈÁø
  • after-pain
    ÈÄÁøÅë(ý­òæ÷Ô).
  • after-vision
    ÀÜ»ó½Ã°¢(íÑßÀò±ÊÆ).
  • nystagmus, optokinetic after [=OKAN]
    ½Ã¿îµ¿(¼º) ÈľÈÁø
  • optokinetic after nystagmus =OKAN
    ½Ã¼±À̵¿¼º ÈľÈÁø.
  • optokinetic after nystagmus =OKAN
    ½Ã¼±À̵¿¼º ÈľÈÁø.
  • optokinetic after nystagmus [=OKAN]
    ½Ã¿îµ¿¼ºÈľÈÁø
  • positive after image
    ¾ç¼ºÀÜ»ó(åÕàõíÑßÀ).
  • positive after potential
    ¾ç¼ºÈÄÀüÀ§(åÕàõý­ï³êÈ).
  • atmospheric pressure change
    ´ë±â¾Ð º¯È­(ÓÞѨäâܨûù)
  • change
    º¯È­(ܨûù), º¯Á¶ (ܨðà).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CHIPS catastrophic health insurance plans
SPD schizotypal personality disorder; sociopathic personality disorder; specific paroxysmal discharge; s...
DEN denervation; dengue; dermatitis exfoliativa neonatorum; Device Experience Network [of the CDRH]; die...
MEDIHC Military Experience Directed Into Health Careers
NDE near-death experience; nondiabetic extremity
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
FAC Fractional area change
HSC Health System Change
MCD Minimal change disease
MCN Minimal change nephropathy
MCNS Minimal change nephrotic syndrome
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • after-sensation
    ÈÄ °¨°¢
    ¿øÀÎÀÌ µÇ¾ú´ø ÀÚ±ØÀÌ Á¦°ÅµÈ ÈÄ¿¡µµ °è¼ÓµÇ´Â Áö°¢.
  • after-vision
    ÀÜ»ó ½Ã°¢
    ÀÚ±ØÀÌ ±×Ä£ ÈÄ¿¡ ³²¾ÆÀÖ´Â ½Ã°¢ÀÇ ÀÜÁ¸.
  • optokinetic after nystagmus
    ½Ã ¿îµ¿ ÈÄ ¾ÈÁø, ½Ã ¿îµ¿¼º ÈÄ ¾ÈÁø
  • positive after potential
    ¾ç¼º ÈÄÀüÀ§
  • soon after birth
    Ãâ»ý Á÷ÈÄ
  • acromegalic personality
    ¼±´Ü °Å´ë¼º ÀΰÝ
  • affective personality
    Á¤µ¿¼º ÀΰÝ
  • anankastic personality
    °­¹Ú¼º ÀΰÝ
  • antisocial personality disorder
    ¹Ý»çȸÀû ÀÎ°Ý Àå¾Ö
  • asthenic personality
    Çã¾à ÀΰÝ
    ÇÇ·ÎÇϱ⠽±°í ±â¿îÀÌ ºÎÁ·Çϸç, Á¤¿­ÀÌ °áÇ̵ǰí Áñ±æÁÙ ¸ð¸£¸ç, À°Ã¼Àû ¶Ç´Â °¨µ¿Àû ½ºÆ®·¹½º¿¡ °ú¹ÎÇÑ ÀΰÝÀå¾Ö.
  • asthmatic personality
    õ½Ä¼º ¼º°Ý
  • avoidant personality
    ȸÇǼº ÀΰÝ
    ´Ù¸¥ »ç¶÷ ¾Õ¿¡¼­ ºÒÆíÇØ ÇÏ°í ´Ù¸¥ »ç¶÷ÀÇ ºñÆÇ¿¡ ¿¹¹ÎÇÏ¸ç ´ëÀÎ Á¢ÃËÀÌ ¿ä±¸µÇ´Â ÀÏÀ» ½È¾îÇϰí ȸÇÇÇÏ´Â °ÍÀ» Ư¡À¸·Î ÇÏ´Â ÀÎ°Ý Àå¾Ö.
  • borderline personality
    °æ°è¼º ÀΰÝÀå¾Ö
    °¨Á¤, Àھƻó ¹× ´ëÀΰü°è°¡ Àü¹ÝÀûÀ¸·Î ÇöÀúÇÏ°Ô ºÒ¾ÈÁ¤ÇÑ ÀΰÝÀå¾Ö·Î Ãæµ¿ÀûÀ̰í ÀÚ±â ÆÄ±«ÀûÀÎ ÇൿÀÌ ÀÚÁÖ ÀÖ°í Á¶Á¾µÇÁö ¾ÊÀº ºÐ³ë, ¹ö¸²¹Þ´Â °Í¿¡ ´ëÇÑ °øÆ÷, ¸¸¼ºÀûÀÌ ±Çۨ°ú °øÇã°¨, ÀÚ»ì À§Çè µîÀÌ ÀÖ´Ù.
  • California Personality Inventory
    ͏®Æ÷´Ï¾Æ Àμº °Ë»ç
  • compulsive personality
    °­¹Ú¼º ÀΰÝ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
chemical change A process in which one or more substances are changed into one or more different substances.
(09 Oct 1997)
minimal-change disease <nephrology> A disorder of the kidneys which largely affects the glomerulus, the blood filtering structure.
This disorder is one common cause of nephrotic syndrome, minimal glomerular changes, in children affecting 2 to 3 children per 100,000 population under age 16 in the USA. Minimal change disease is also seen rarely in adults. The cause is unknown but may be related to an autoimmune illness.
It is marked by oedema, albuminuria, and an increase in cholesterol in the blood, but otherwise with fairly good renal function. Tubular epithelium is vacuolated by cholesterol droplets, but the glomeruli show only that the foot processes of the glomerular epithelial cells are fused, probably secondary to the proteinuria; the cause of the increased glomerular permeability to plasma protein is unknown.
Risk factors include a history for a immune disorder, recent immunisation or a bee sting.
Diagnosis is made by renal biopsy.
Treatment include systemic corticosteroids which are usually quite effective in curing this disease. Other medications include chlorambucil and cyclophosphamide. In most cases, a moderate protein diet (1 gram protein per Kg body weight per day) will be recommended. Salt (sodium) restriction can be helpful to reduce swelling and vitamin D is usually supplemented.
Synonym: lipoid nephrosis
(27 Sep 1997)
minimal-change nephrotic syndrome <nephrology> A disorder of the kidneys which largely affects the glomerulus, the blood filtering structure.
This disorder is one common cause of nephrotic syndrome, minimal glomerular changes, in children affecting 2 to 3 children per 100,000 population under age 16 in the USA. Minimal change disease is also seen rarely in adults. The cause is unknown but may be related to an autoimmune illness.
It is marked by oedema, albuminuria, and an increase in cholesterol in the blood, but otherwise with fairly good renal function. Tubular epithelium is vacuolated by cholesterol droplets, but the glomeruli show only that the foot processes of the glomerular epithelial cells are fused, probably secondary to the proteinuria; the cause of the increased glomerular permeability to plasma protein is unknown.
Risk factors include a history for a immune disorder, recent immunisation or a bee sting.
Diagnosis is made by renal biopsy.
Treatment include systemic corticosteroids which are usually quite effective in curing this disease. Other medications include chlorambucil and cyclophosphamide. In most cases, a moderate protein diet (1 gram protein per Kg body weight per day) will be recommended. Salt (sodium) restriction can be helpful to reduce swelling and vitamin D is usually supplemented.
Synonym: lipoid nephrosis
(27 Sep 1997)
conformational change <cell biology> Alteration in the shape usually the tertiary structure of a protein as a result of alteration in the environment pH, temperature, ionic strength) or the binding of a ligand (to a receptor) or binding of substrate (to an enzyme).
(18 Nov 1997)
Crooke's hyaline change Replacement of cytoplasmic granules of basophil cells of the anterior pituitary by homogenous hyaline material; a characteristic finding in Cushing's syndrome, but usually not present in the cells of a basophil adenoma.
Synonym: Crooke's hyaline degeneration.
(05 Mar 2000)
social change Social process whereby the values, attitudes, or institutions of society, such as education, family, religion, and industry become modified. It includes both the natural process and action programs initiated by members of the community.
(12 Dec 1998)
enthalpy change <chemistry> In a reaction, this is more or less equal to the difference between the energy put into breaking bonds and the enery gained from new bond formation.
(13 Oct 1997)
epigenetic change <biology> Any changes in an organism brought about by alterations in the action of genes are called epigenetic changes.
Epigenetic transformation refers to those processes which cause normal cells to become tumour cells without the occurrence of any mutations.
(07 May 1998)
fatty change The appearance of microscopically visible droplets of fat in the cytoplasm of cells.
See: fatty degeneration.
Synonym: fatty change.
(05 Mar 2000)
life change events Those occurrences, including social, psychological, and environmental, which require an adjustment or effect a change in an individual's pattern of living.
(12 Dec 1998)
affective personality disorder A disturbance of feelings or mood expressed as a milder form of depression and related emotional features that colour the whole psychic life and for which psychosocial stressors are believed to play the major role.
(05 Mar 2000)
allotropic personality See: allotropic.
(05 Mar 2000)
anancastic personality An obsolete term for obsessive-compulsive personality disorder.
(05 Mar 2000)
antisocial personality A personality disorder characterised by a continuous and persistent pattern of aggressive behaviour in which the rights of others are violated.
See: psychopath, sociopath.
Synonym: psychopathic personality.
(05 Mar 2000)
antisocial personality disorder <psychiatry> An individual who engages in deviant behaviour with lack of remorse.
(13 Jan 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • run after
    ÃßÀûÇÏ´Ù; µû¶ó´Ù´Ï´Ù
  • take after
    -¸¦ ´à´Ù
  • after
    (...ÀÇ)µÚ¿¡;...ÇÏ¿´À¸¹Ç·Î;...ÇÏ°í³ª¼­;...À» ã¾Æ¼­;...¿¡ µû¶ó¼­
  • morning after
    ¼÷Ãë;(¾Ç¿¡¼­ÀÇ)´µ¿ìħ
  • amount of change
    ¸¹Àº Àܵ·(µ¿Àü)
  • change
    º¯È­,±³È¯,º¯È­ÇÏ´Ù,±³È¯ÇÏ´Ù,Àܵ·,µ¿Àü
  • change hands
    ÁÖÀÎÀÌ ¹Ù²î´Ù
  • change
    ¹Ù²Ù´Ù;º¯È­½ÃŰ´Ù;º¯°æÇÏ´Ù;°íÄ¡´Ù;(¿ÊÀ»)...À¸·Î °¥¾Æ ÀÔ´Ù;(ħ´ëÀÇ)½ÃÆ®¸¦ °¥´Ù;(¾î¸°¾ÆÀÌÀÇ)±âÀú±Í¸¦ °¥´Ù;ȯÀüÇÏ´Ù;Àܵ·À¸·Î ¹Ù²Ù´Ù;(¼öÇ¥.¾îÀ½.ȯÀ»)Çö±ÝÀ¸·Î ¹Ù²Ù´Ù;±³È¯ÇÏ´Ù;(Àå¼Ò.ÀÔÀåµîÀ»)¹Ù²Ù´Ù;(Å»°ÍÀ»)°¥¾ÆÅ¸´Ù;¹Ù²ãŸ´Ù;º¯ÇÏ´Ù;¹Ù²î´Ù;º¯È­ÇÏ´Ù;(´Þ.Á¶¼öµîÀÌ)
  • change gear
    (ÀÚµ¿Â÷.±â°èÀÇ)º¯¼Ó±â ÀåÄ¡
  • change machine
    Àܵ· ±³È¯±â
  • change ringing
    (±³È¸ µîÀÇ)ÀüÁ¶ ¸íÁ¾(¹ý)(Á¾À» ¿©·¯°¡Áö À½»ö,ƯÈ÷ 4ºÐÀ½°è·Î ¿ï¸®±â)
  • change wheel
    Àüȯ Åé´Ï¹ÙÄû 
  • change-down
    (ÀÚµ¿Â÷µîÀÇ ±â¾î¸¦)Àú¼ÓÀ¸·Î ¹Ù²Ù±â
  • change-of-ends
    üÀÎÁöÄÚÆ®;ÄÚÆ®±³Ã¼
  • change-up
    üÀÎÁö¾÷(ŸÀÚÀÇ Å¸À̹ÖÀ» ¾î±ß³ª°Ô Çϱâ À§ÇØ ¼Ó±¸ °°Àº ¸ð¼ÇÀ¸·Î ´øÁö´Â ¿Ï±¸)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á